Device Orthopedic

Photodynamic Bone Stabilization Procedure Pack

Payments companies reported to CMS as associated with Photodynamic Bone Stabilization Procedure Pack. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$393Kassociated payments (2023-2025)
744clinicians with associated payments
2companies reporting

By year

2023 $122K
2024 $141K
2025 $130K

Payments reported as associated with Photodynamic Bone Stabilization Procedure Pack, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $253K
Orthopaedic Trauma $93K
Adult Reconstructive Orthopaedic Surgery $13K
Sports Medicine (Orthopaedic Surgery) $4,502
Vascular & Interventional Radiology $3,705
Hand Surgery $2,190

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Photodynamic Bone Stabilization Procedure Pack

These are the largest totals companies reported as associated with Photodynamic Bone Stabilization Procedure Pack. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
William Harvin Katy, TX Orthopaedic Surgery $69,384.31
Santiago Lozano Calderon Boston, MA Orthopaedic Surgery $56,048.73
Kyle Mobley Tallahassee, FL Orthopaedic Surgery $26,094.04
John Scolaro Orange, CA Orthopaedic Trauma $18,172.62
Steven Morgan Englewood, CO Orthopaedic Surgery $16,022.14
Christopher Born Providence, RI Orthopaedic Trauma $13,665.00
Jason Halvorson Winston Salem, NC $11,252.93
Brooke Crawford Miami, FL Orthopaedic Surgery $8,452.77
James Hlavacek Lafayette, LA Orthopaedic Trauma $8,125.47
Hank Hutchinson Tallahassee, FL Orthopaedic Surgery $7,780.54

Prescribed Photodynamic Bone Stabilization Procedure Pack?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.